Photocure ASA ( ($PHCUF) ) has shared an announcement. Photocure ASA reported a strong financial performance for the fourth quarter of 2024, with ...

Photocure ASA (OSE:PHO) today reported Hexvix®/Cysview® revenues of NOK 128.6 million in the fourth quarter of 2024 (Q4 2023: NOK ...

Tommy was diagnosed with bladder cancer just before his 60th birthday. Now, thanks to a Cancer Research UK trial, he’s enjoying playing ...

Among patients with low-grade, intermediate-risk NMIBC, UGN-102 generated robust, durable responses in an analysis of the ...

The Bladder Cancer Company, announces the presentation on February 14 of a new abstract with study results from its U.S. bladder cancer patient registry at the 2025 American Society of Clinical ...